- ISIN
- US29261A1007
- CUSIP
- 29261A100
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- IPO Date
- Sep 30, 1986
Highlights
- Market Cap
- $10.93B
- Enterprise Value
- $11.15B
- EPS (TTM)
- $5.99
- PE Ratio
- 18.38
- PEG Ratio
- 1.53
- Total Revenue (TTM)
- $6.07B
- Gross Profit (TTM)
- $2.44B
- EBITDA (TTM)
- $1.42B
- Year Range
- $92.77 - $127.99
- Target Price
- $153.00
- ROA (TTM)
- 8.33%
- ROE (TTM)
- 18.41%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
EHC Performance Chart
Encompass Health Corporation (EHC) is up 4.4% since the beginning of the year. At $110 per share, EHC is trading 13.9% below its 52-week high of $128. Investors who bought $1,000 worth of EHC shares 5 years ago would now be looking at an investment worth $1,786.
Loading charts...
Returns By Period
Encompass Health Corporation (EHC) has returned 4.37% so far this year and -6.32% over the past 12 months.
Encompass Health Corporation
- 1D
- -0.77%
- 1M
- 8.77%
- 6M
- 7.44%
- YTD
- 4.37%
- 1Y
- -6.32%
- 3Y*
- 18.96%
- 5Y*
- 12.30%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- 0.42%
- 1M
- 1.94%
- 6M
- 8.74%
- YTD
- 10.66%
- 1Y
- 21.02%
- 3Y*
- 19.50%
- 5Y*
- 11.63%
- 10Y*
- 13.41%
EHC Monthly Returns History
Based on dividend-adjusted daily data since Dec 29, 2017, EHC's average daily return is +0.07%, while the average monthly return is +1.46%. At this rate, an investment would double in approximately 4.0 years.
Historically, 63% of months were positive and 38% were negative. The best month was Nov 2020 with a return of +31.4%, while the worst month was Dec 2018 at -17.6%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 4 months.
On a daily basis, EHC closed higher 51% of trading days. The best single day was Apr 25, 2025 with a return of +11.8%, while the worst single day was Mar 11, 2020 at -11.0%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -10.78% | 14.12% | -10.34% | 3.58% | 5.85% | -4.51% | 9.19% | 4.37% | |||||
| 2025 | 7.69% | 0.88% | 1.14% | 15.71% | 3.34% | 1.43% | -10.08% | 10.58% | 4.32% | -10.23% | 2.08% | -8.67% | 15.67% |
| 2024 | 6.47% | 4.73% | 11.21% | 0.97% | 3.61% | -0.69% | 8.52% | 0.12% | 3.86% | 3.10% | 3.50% | -10.29% | 39.17% |
| 2023 | 4.41% | -9.50% | -4.01% | 18.58% | -3.32% | 9.42% | -2.48% | 7.59% | -5.25% | -6.85% | 4.17% | 2.61% | 12.62% |
| 2022 | -4.93% | 6.42% | 8.14% | -3.21% | -4.78% | -14.48% | 13.96% | -4.05% | -6.57% | 20.36% | 7.42% | 2.53% | 16.77% |
| 2021 | -2.77% | 0.05% | 2.16% | 3.61% | 1.10% | -8.72% | 6.69% | -5.77% | -4.00% | -15.30% | -9.35% | 13.74% | -19.90% |
Benchmark Metrics
Encompass Health Corporation has an annualized alpha of 7.33%, beta of 0.73, and R2 of 0.25 versus S&P 500 Index. Calculated based on daily prices since December 29, 2017.
- This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (86.85%) than losses (79.34%) - typical of diversified or defensive assets.
- R2 of 0.25 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 7.33%
- Beta
- 0.73
- R²
- 0.25
- Upside Capture
- 86.85%
- Downside Capture
- 79.34%
Return for Risk
Risk / Return Rank
EHC ranks 35 for risk / return — below 35% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Encompass Health Corporation (EHC) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| EHC | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.85 | ||
| Sortino ratioReturn per unit of downside risk | -2.38 | ||
| Omega ratioGain probability vs. loss probability | 0.99 | 1.30 | -0.31 |
| Calmar ratioReturn relative to maximum drawdown | -0.21 | 2.28 | -2.49 |
| Martin ratioReturn relative to average drawdown | -0.38 | 9.88 | -10.26 |
Dividends
Dividend History
Encompass Health Corporation provided a 0.69% dividend yield over the last twelve months, with an annual payout of $0.76 per share.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.76 | $0.70 | $0.47 | $0.60 | $12.23 | $1.12 | $1.12 | $1.10 | $1.04 | $0.25 |
Dividend yield | 0.69% | 0.66% | 0.51% | 0.90% | 20.45% | 1.72% | 1.35% | 1.59% | 1.69% | 0.51% |
Monthly Dividends
The table displays the monthly dividend distributions for Encompass Health Corporation. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.19 | $0.00 | $0.00 | $0.19 | $0.00 | $0.00 | $0.19 | $0.57 | |||||
| 2025 | $0.17 | $0.00 | $0.00 | $0.17 | $0.00 | $0.00 | $0.17 | $0.00 | $0.00 | $0.19 | $0.00 | $0.00 | $0.70 |
| 2024 | $0.00 | $0.00 | $0.15 | $0.00 | $0.00 | $0.00 | $0.15 | $0.00 | $0.00 | $0.17 | $0.00 | $0.00 | $0.47 |
| 2023 | $0.00 | $0.00 | $0.15 | $0.00 | $0.00 | $0.15 | $0.00 | $0.00 | $0.15 | $0.00 | $0.00 | $0.15 | $0.60 |
| 2022 | $0.00 | $0.00 | $0.28 | $0.00 | $0.00 | $0.00 | $11.65 | $0.00 | $0.15 | $0.00 | $0.00 | $0.15 | $12.23 |
| 2021 | $0.00 | $0.00 | $0.28 | $0.00 | $0.00 | $0.28 | $0.00 | $0.00 | $0.28 | $0.00 | $0.00 | $0.28 | $1.12 |
Dividend Yield & Payout
Dividend Yield
Encompass Health Corporation has a dividend yield of 0.69%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
Encompass Health Corporation has a payout ratio of 12.05%, which is below the market average. This means Encompass Health Corporation returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Encompass Health Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Encompass Health Corporation was 39.54%, occurring on Mar 23, 2020. Recovery took 172 trading sessions.
The current Encompass Health Corporation drawdown is 12.89%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
COVID crash2020 | -39.54%Mar 2020 | 1mo 2d | 8mo 6d | 9mo 8dFeb 2020 - Nov 2020 |
Bear market2022 | -38.16%Jun 2022 | 1y 1mo | 1y 29d | 2y 2moApr 2021 - Jul 2023 |
2019 bear market2019 | -29.04%Apr 2019 | 7mo 27d | 9mo 29d | 1y 5moAug 2018 - Feb 2020 |
2026 bear market2026 | -26.09%Feb 2026 | 3mo 7d | — | 8mo 18dOct 2025 - now |
2023 correction2023 | -15.38%Oct 2023 | 2mo 16d | 2mo 28d | 5mo 14dAug 2023 - Jan 2024 |
Drawdown Indicators
| EHC | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -39.54% | -56.78% | +17.24% |
Max Drawdown (1Y)Largest decline over 1 year | -26.09% | -9.10% | -16.99% |
Max Drawdown (3Y)Largest decline over 3 years | -26.09% | -18.90% | -7.19% |
Max Drawdown (5Y)Largest decline over 5 years | -35.10% | -25.43% | -9.67% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -12.89% | -0.45% | -12.44% |
Average DrawdownAverage peak-to-trough decline | -12.16% | -10.71% | -1.45% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 14.66% | 2.09% | +12.57% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Encompass Health Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Encompass Health Corporation is priced in the market compared to other companies in the Medical Care Facilities industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for EHC, comparing it with other companies in the Medical Care Facilities industry. Currently, EHC has a P/E ratio of 18.4. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for EHC compared to other companies in the Medical Care Facilities industry. EHC currently has a PEG ratio of 1.5. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for EHC relative to other companies in the Medical Care Facilities industry. Currently, EHC has a P/S ratio of 1.8. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for EHC in comparison with other companies in the Medical Care Facilities industry. Currently, EHC has a P/B value of 3.3. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with EHC
Add Encompass Health Corporation to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with EHC